How MDMA's Pharmacology and Pharmacokinetics Drive Desired Effects and Harms

3,4‐Methylenedioxymethamphetamine (MDMA) is an agent of abuse that has been used by over 16 million Americans. Increased energy, elevated mood, bonding with others, and psychedelic effects are desired effects while liver damage, extended depressed mood, sexual assault, rhabdomyolysis, serotonin synd...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical pharmacology 2014-03, Vol.54 (3), p.245-252
1. Verfasser:	Michael White, C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Drug Interactions Ecstasy Europe - epidemiology Hallucinogens - adverse effects Hallucinogens - pharmacokinetics Hallucinogens - pharmacology Humans hyperpyrexia hyponatremia MDMA molly N-Methyl-3,4-methylenedioxyamphetamine - adverse effects N-Methyl-3,4-methylenedioxyamphetamine - pharmacokinetics N-Methyl-3,4-methylenedioxyamphetamine - pharmacology Prevalence rhabdomyolysis Serotonin Agents - adverse effects Serotonin Agents - pharmacokinetics Serotonin Agents - pharmacology Street Drugs - adverse effects Street Drugs - pharmacokinetics Street Drugs - pharmacology Substance-Related Disorders - epidemiology United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!